Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin B Boylan

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 20, 2009
Total laryngectomy in patients with advanced bulbar symptoms of amyotrophic lateral sclerosisChristopher M Garvey, Kevin B Boylan, John R Salassa, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|January 20, 2009
Defining normal duration for afterdischarges with repetitive nerve stimulation: a pilot studyCynthia L Bodkin, Kathleen D Kennelly, Kevin B Boylan, et al.
Mayo Clinic Proceedings|December 14, 2002
Utility of subcutaneous fat aspiration for diagnosing amyloidosis in patients with isolated peripheral neuropathyTricia R Andrews, Gerardo Colon-Otero, Kenneth T Calamia, et al.
Parkinsonism & Related Disorders|October 20, 2006
Aprataxin (APTX) gene mutations resembling multiple system atrophyYasuhiko Baba, Ryan J Uitti, Kevin B Boylan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 3, 2012
Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosisKevin B Boylan, Jonathan D Glass, Julia E Crook, et al.
Acta Neuropathologica|October 12, 2012
Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansionKevin F Bieniek, Melissa E Murray, Nicola J Rutherford, et al.
Neurology|April 19, 2013
Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosisAshley Cannon, Shinsuke Fujioka, Nicola J Rutherford, et al.
Experimental Neurology|January 10, 2016
C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cellsRustam Esanov, Kinsley C Belle, Marka van Blitterswijk, et al.
Parkinsonism & Related Disorders|December 13, 2012
TARDBP mutations in Parkinson's diseaseSruti Rayaprolu, Shinsuke Fujioka, Sharleen Traynor, et al.
Acta Neuropathologica|November 16, 2011
Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72Melissa E Murray, Mariely DeJesus-Hernandez, Nicola J Rutherford, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 20, 2009
Total laryngectomy in patients with advanced bulbar symptoms of amyotrophic lateral sclerosisChristopher M Garvey, Kevin B Boylan, John R Salassa, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|January 20, 2009
Defining normal duration for afterdischarges with repetitive nerve stimulation: a pilot studyCynthia L Bodkin, Kathleen D Kennelly, Kevin B Boylan, et al.
Mayo Clinic Proceedings|December 14, 2002
Utility of subcutaneous fat aspiration for diagnosing amyloidosis in patients with isolated peripheral neuropathyTricia R Andrews, Gerardo Colon-Otero, Kenneth T Calamia, et al.
Parkinsonism & Related Disorders|October 20, 2006
Aprataxin (APTX) gene mutations resembling multiple system atrophyYasuhiko Baba, Ryan J Uitti, Kevin B Boylan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 3, 2012
Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosisKevin B Boylan, Jonathan D Glass, Julia E Crook, et al.
Acta Neuropathologica|October 12, 2012
Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansionKevin F Bieniek, Melissa E Murray, Nicola J Rutherford, et al.
Neurology|April 19, 2013
Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosisAshley Cannon, Shinsuke Fujioka, Nicola J Rutherford, et al.
Experimental Neurology|January 10, 2016
C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cellsRustam Esanov, Kinsley C Belle, Marka van Blitterswijk, et al.
Parkinsonism & Related Disorders|December 13, 2012
TARDBP mutations in Parkinson's diseaseSruti Rayaprolu, Shinsuke Fujioka, Sharleen Traynor, et al.
Acta Neuropathologica|November 16, 2011
Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72Melissa E Murray, Mariely DeJesus-Hernandez, Nicola J Rutherford, et al.
Pageof 5